Cambridge, MA, United States of America

Katherine Collins

This inventor holds 1 USPTO granted patent. Top assignees: Harvard College, Massachusetts Institute of Technology. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katherine Collins: Innovator in Riboregulators

Introduction

Katherine Collins is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly through her innovative work on riboregulators. Her research focuses on developing specific riboregulators that can detect particular viruses and human transcription factors, which has important implications for medical diagnostics.

Latest Patents

Katherine Collins holds 1 patent for her invention titled "Riboregulators and methods of use thereof." This patent provides a novel approach to detecting the presence of specific viruses, enabling timely diagnosis of infections. Additionally, her transcription factor-specific riboregulators can measure the levels of particular transcription factors, aiding in the diagnosis and prognosis of conditions such as cancer.

Career Highlights

Throughout her career, Katherine has worked with prestigious institutions, including Harvard College and the Massachusetts Institute of Technology. Her work has garnered attention for its potential to revolutionize diagnostic methods in healthcare.

Collaborations

Katherine has collaborated with notable colleagues, including Luis Ruben Soenksen Martinez and Nicolaas Angenent-Mari. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Katherine Collins is a trailblazer in the development of riboregulators, with her work paving the way for advancements in medical diagnostics. Her contributions to biotechnology are invaluable and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…